Salter Malcolm 4
4 · C4 Therapeutics, Inc. · Filed Jun 21, 2024
Insider Transaction Report
Form 4
Salter Malcolm
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-06-20+32,500→ 32,500 totalExercise: $4.05Exp: 2034-06-19→ Common Stock (32,500 underlying)
Footnotes (1)
- [F1]This option shall vest and become exercisable in full upon the earlier to occur of (i) June 20, 2025 and (ii) the next annual meeting of the Issuer's stockholders, subject to the recipient's continued service as a member of the Board on such date.